IAS 2014, Melbourne Mechanisms of non-pathogenicity in HIV- Lessons from paediatric infection.

Slides:



Advertisements
Similar presentations
“ The therapeutic effect of FIT- 06, GTU®-Multi-HIVB DNA vaccine, observed in HIV-1 infected people. Results of a Phase II trial”. Prof. Mart Ustav SVP,
Advertisements

Monica Gandhi MD, MPH Associate Professor and Women’s HIV Clinic provider, HIV/AIDS Division San Francisco General Hospital/ UCSF Safe Poz Love, U.S. Positive.
Natural control of HIV infection is associated with an isotype switched IgG antibody response to HIV Gag antigens in patients with 'non-protective' HLA-B.
Protective HLA Class I alleles are associated with reduced immune activation in Primary HIV infection Elizabeth Hamlyn 1, Stephen Hickling 2, Abdel Babiker.
Viral load, CD4 cell counts and antibodies: What do we know and what does it all mean? Brian Williams, SACEMA, November 2007.
Rafael Correa Rocha Clinical & Cellular Immunology
Natural History and Clinical Staging of HIV Training for Medical Officers Day 2 Session 7.
Cell- and Tissue-based Measures of Viral Persistence Are Associated with Immune Activation and PD-1-Expressing CD4+ T cells H Hatano 1, V Jain 1, PW Hunt.
Human Immunodeficiency Virus Part II VIRUSES. TYPES OF HIV There are two types of HIV HIV-1 and HIV-2 Can be distinguished genetically and antigenically.
HIV-1 DNA levels after antiretroviral therapy in primary infection predict disease progression: the SPARTAC Trial James Williams 1,2,3, Jacob Hurst 1,2,3,
DNA methylation as an epigenetic marker in HIV-2 disease in West Africa? Alberta Davis MRC Laboratories, Gambia 18th January 2013.
Pongphol Pongthaisong Animal Immunology 6 Feb 2014.
Supplementary Table 1 Table S1. Population frequency of HLA -A, -B and -C alleles. Rare alleles (frequency < 0.5%) are highlighted by a grey background.
Analysis of HIV Evolution Bobak Seddighzadeh and Kristoffer Chin Department of Biology Loyola Marymount University Bio February 23, 2010.
CD4+ memory stem cells (T SCM ) in pathogenic and non- pathogenic SIV infections Guido Silvestri, MD Yerkes National Primate Research Center Emory University.
The Influence of CCL3L1 Gene- Containing Segmental Duplications on HIV-1/AIDS Susceptibility Gonzalez et al. Mar 4, 2005 :307 Science Presenter: Braydon.
Long-term ART initiated during primary HIV-1 infection limits the HIV-1 reservoir size but not to levels found in LTNPs Eva Malatinkova, Ward De Spiegelaere,
Assessing the Response to Hepatitis B Immunizations in HIV-Positive Adults: Results from the 550 Clinic cohort study Camila Calderon 1, Anupama Raghuram.
Slide 1 of 11 From DA Wohl, MD, at New York, NY: May 03, 2012, IAS-USA. IAS–USA David Alain Wohl, MD Associate Professor of Medicine The University of.
Pavel Bostik FMHS Charles University Medical School University Hospital Hradec Kralove Czech Republic DIFFERENTIAL EFFECTS OF (LENTI)VIRUS INFECTION ON.
Antibody and B cell responses may control circulating lipopolysaccharide in patients with HIV infection Lim A 1, Amini A 1, D’Orsogna L 2, Rajasuriar R.
Clinical Care of HIV, AIDS and Opportunistic Infections
HIV-1 evolution in response to immune selection pressures
The evolution of HIV Why is HIV fatal?. Lethal strains are favored, due to “Short sighted” evolution within hosts Transmission rate advantages.
Population-based impact of ART in high HIV prevalence settings Marie-Louise Newell Professor of Global Health Faculty of Medicine, Faculty of Social and.
Examining Subjects of HIV-1 With Possible Predominant Viral Strains Samantha Hurndon Isaiah Castaneda.
Older and wiser: continued improvements in clinical outcome and highly active antiretroviral therapy (HAART) response in HIV-infected children in the UK.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
Naive CD4 T lymphocytes and recent thymic emigrants, 15 or more years after perinatal HIV infection The ANRS-EP38-IMMIP study Stéphane Blanche, Daniel.
GAP Report 2014 People left behind: People aged 50 years and older Link with the pdf, People aged 50 years and older.
EARLY CHILDHOOD OUTCOMES AT THE BOTSWANA- BAYLOR CHILDREN’S CLINICAL CENTRE OF EXCELLENCE: A REPORT TO THE WHO TECHNICAL REFERENCE GROUP ON PEDIATRIC CARE.
Mirko Paiardini, PhD Emory University, YNPRC
HIV-1 infected subjects treated with an autologous dendritic cell therapy (AGS-004), exhibited a significant reduction in viral load (when compared to.
Ad5 expressing Gag, Pol and Nef Immune responses in control of HIV replication non-human primates // SIV extrapolated to humans // HIV Prospects for.
Functional cure after long term HAART initiated during early HIV infection - a case study. van Lunzen J. 1,2, Schulze zur Wiesch J. 1,2, Schumacher U.
Data from the Collaborative HIV Paediatric Study (CHIPS) Reports up to March 2006* *Numbers are based on reports received rather than children seen to.
Diversity and Divergence in HIV-1 Viral Variants between patients with high CD4+ T Cell Variability and Patients with Rapid CD4+ T Cell Decline Kevin Paiz-Ramirez.
HIV DISEASE IN PREGNANCY
What are possible biomarkers for cure-related interventions ? Lars Ostergaard, MD, Ph.D., DMSc Prof/Head Dept of infectious diseases Aarhus.
Title Box. “Towards an HIV Cure”: Presentation Outline -Why do we need a cure? -Is a cure feasible and what type of cure can we reach? -Why does HAART.
Interactions between viral infections and allergy in exacerbating asthma.
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
Evolution of the Functional Profile of HIV-Specific CD8+ T cells in a Cohort of Long Term Nonprogressors M López, N Rallón, A Peris, M Salgado, B Rodés,
@PtSafetyIntl #PSC14 #PSC14 Workshop 3.
Can early antiretroviral therapy fully restore health? Workshop on Pathogeneses and Management of Long-Term Complications of ART IAS Conference, Rome July.
This presentation is intended for educational use only, and does not in any way constitute medical consultation or advice related to any specific patient.
Update on Genetic Links to HCV Clearance Todd Wills, MD ETAC Infectious Disease Specialist HEPATITIS C TREATMENT EXPANSION INITIATIVE MULTISITE CONFERENCE.
HUMAN IMMUNODEFICIENCY VIRUS AND ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
Impact of immune-driven sequence variation in HIV- 1 subtype C Gag-protease on viral fitness and clinical outcome Thumbi Ndung’u, BVM, PhD HIV Pathogenesis.
HIV co-receptor tropism in treatment-naïve patients: impact on CD4 decline and subsequent response to HAART Laura Waters, Sundhiya Mandalia, Adrian Wildfire,
Background  HIV-1 infection persists in reservoirs and leads to progressive depletion of CD4+ T-cells even in subjects with slow disease progression 
Host Susceptibility and Resistance to HIV. Relative hazards for genetic associations with progression to AIDS Non-HLA genetic associations with progression.
The AIDS resistance of naturally SIV-infected sooty mangabeys is independent of cellular immunity to the virus by Richard Dunham, Paola Pagliardini, Shari.
Dysbiotic bacteria drive suppressive neutrophil phenotypes and prolonged lifespan in mucosal tissues of HIV-infected individuals Nichole Klatt AIDS 2016,
Viral and Host characteristics of a child with perinatal HIV-1 after prolonged period of ART cessation in the CHER trial Avy Violari, Mark Cotton, Louise.
Catherine K. Koofhethile 21st IAS July,2016 Durban, SA
HIV Cure: Current Status and Future Perspectives
PANEL 1 All events Lymphocytes (FSC-A v SSC-A)
Table 3. Comparison of NS1 Antigen Assay and Platelet Counts
Closing the Treatment Gap of Children Living with HIV
Cepheid Symposium, IAS 23rd July 2018
Expansion of CD7low and CD7negative CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment.
The protective compared to other B. Rodés,
Jason M. Brenchley, Guido Silvestri, Daniel C. Douek  Immunity 
Human Immunodeficiency Virus Controllers: Mechanisms of Durable Virus Control in the Absence of Antiretroviral Therapy  Steven G. Deeks, Bruce D. Walker 
Immunological phenotypes of CD4+ T cells preferentially infected by HIV. PBMCs exposed to HIV-1BaL (MOI 0.01) were cultured for 10 d. Immunological phenotypes.
Volume 43, Issue 3, Pages (September 2015)
HIV and HLA Class I: An Evolving Relationship
Volume 18, Issue 3, Pages (March 2003)
Keep control: Elite and post-treatment controllers
Presentation transcript:

IAS 2014, Melbourne Mechanisms of non-pathogenicity in HIV- Lessons from paediatric infection

PS-517-C dob Jan 2005 HLA A*30:02/68:02 B*15:10/42:01 C*03:03/17:01 PS-517-M HLA-A*30:02/30:04 B*42:01/58:02 C*06:02/17:01 No protective HLA alleles Representative example of a paediatric ‘non-progressor’

90 th c 10 th c 90 th c 10 th c Uninfected childrenPS-517-C CD4% Absolute CD4 CD4 count changes from birth in PS-517-C

CD4% Absolute CD4 CD4 count changes from birth in PS-517-C

High CD4 counts in the setting of persistently high viral loads 90 th c 10 th c 90 th c 10 th c Uninfected childrenPS-517-C Absolute CD4 CD4%

In HIV-infected children with normal CD4 counts viral loads decline over 5yrs to a ‘setpoint’ of

Normal CD4 counts in the setting of persistently high viral loads

Sooty Mangabeys African Greens Adult viraemic non-progressors Silvestri et al, Immunity 2003 Bosinger et al, JCI 2009 Rotger et al, JCI 2011 Normal CD4 counts in the setting of persistently high viral loads  Attenuated immune activation  Avoid bystander damage  Preserve T cell populations  Protects from AIDS  Asymptomatic  Preserve T cell populations

Potential mechanism: Low immune activation despite persistent high viral loads

Representative CD4 data Potential mechanism: Low immune activation despite persistent high viral loads Lack of progression to AIDS = Attenuated immune activation

Normal range for uninfected age-matched children n=19n=28n=44n=25 p=0.002p=0.004 n=19n=28n=44n=25 Immune activation: strongly correlated with CD4 count in ART-naïve paediatric infection

No relationship between immune activation and viral load in paediatric infection r=0.11 p=ns

Response to SEB; Muenchhoff et al unpublished Defect in IL-2 production by CD4 cells in progressors versus non progressors

Response to SEB; Muenchhoff et al unpublished r=0.58 p< IL-2 response in CD4 cells in ART-naïve children is strongly correlated to CD4 count

Consistent with sooty mangabey and adult viraemic non progressors Paiardini et al, Nature Medicine 2012 Klatt et al, Plos Path 2014 Low CCR5 expression on central memory CD4 cells correlates with high CD4 count in paediatric HIV

Viral load CD4 count Antenatal CD4 PS-517-M is an adult viraemic non-progressor

Viral load Mothers of paediatric non- progressors Mothers of paediatric progressors r = p = ns r = p < Absolute CD Log viral load Mothers of paediatric non-progressors include a significant number of AVNPs

1.‘Non-progressors’ (normal CD4) 1.‘Viral controllers’ (viral load <1000) Paediatric ‘elites’

GOS-041-C 12yo CD4 1250/mm 3 CD4% 42% VL<50 Paediatric ‘elites’

GOS-041-C 12yo CD4 1250/mm 3 CD4% 42% VL<50 Negative GOS-041-C Positive Paediatric ‘elites’

GOS-041-C 12yo CD4 1250/mm 3 CD4% 42% VL<50 HLA-B*57:03 Adult elite controllers – enrichment of protective HLA alleles Negative GOS-041-C Positive Paediatric ‘elites’

Distinct strategies to non-pathogenicity in paediatric infection -‘Non-progressor’ – high CD4/high viral load: sooty mangabey-type -‘Viral controller’ – high CD4/low viral load: Elite controller-type Conclusion

The University of Oxford Professor Philip Goulder Dr Paolo Paioni Dr Jacob Hurst Dr Henrik Kloverpris Dr Max Muenchhoff Goulder Group Kimberley Hospital, South Africa Dr Pieter Jooste Acknowledgements Great Ormond Street Hospital, London UK Gareth Tudor-Williams, St Marys Hospital, London UK

Sooty Mangabey – Similar Phenotype to PSP? Bosinger et al JCI 2009